Panel: Why Building a Collaborative Network is Essential for Rare Disease Therapies

Wednesday, October 25, 2023 10:55 AM to 11:40 AM · 45 min. (Africa/Abidjan)

CPHI Content Hub - CC4.3

Conference

Future Therapies

Information

To watch on-demand, head over to CPHI Online. Click 'Events and Webinars' and find Event Content there. Presentations are shared at the speakers discretion.

SeqensSEQENS is a worldwide leader in the development and production of pharmaceutical solutions leveraging a strong industrial network, 10 R&D centers and 3,500 employees in 9 countries. As an integrated player across the value chain - from raw materials to active ingredients and from research and development to industrialization - SEQENS offers a broad portfolio of APIs, pharmaceutical intermediates and excipients.

Registered attendees

Berk Ozkislali

ProcurementBayer Consumer Care AG

Charlene Lu

MarketingWest Pharmaceutical Services

CLJ

Chris Lassen Jensen

Director, Corporate ProcurementH. Lundbeck A/S

Panel: Why Building a Collaborative Network is Essential for Rare Disease Therapies

Information

Registered attendees

Log in

Log in